TY - JOUR T1 - Gabapentin and risk of severe respiratory depression JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull DO - 10.1136/dtb.2018.1.0571 SP - dtb.2018.1.0571 A2 - , Y1 - 2017/12/28 UR - http://dtb.bmj.com/content/early/2017/12/28/dtb.2018.1.0571.abstract N2 - In a recent Drug Safety Update, the Medicines and Healthcare products Regulatory Agency (MHRA) warned about a rare risk of severe respiratory depression with gabapentin, with or without concomitant use of opioids.1 In England, 6.5 million prescriptions for gabapentin were dispensed in 2016.2A European review of gabapentin was triggered by reports of patients developing respiratory depression without concomitant … ER -